U.S. flag

An official website of the United States government

NM_024675.4(PALB2):c.1676A>G (p.Gln559Arg) AND Familial cancer of breast

Germline classification:
Benign/Likely benign (3 submissions)
Last evaluated:
Feb 1, 2024
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000114486.23

Allele description [Variation Report for NM_024675.4(PALB2):c.1676A>G (p.Gln559Arg)]

NM_024675.4(PALB2):c.1676A>G (p.Gln559Arg)

Gene:
PALB2:partner and localizer of BRCA2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
16p12.2
Genomic location:
Preferred name:
NM_024675.4(PALB2):c.1676A>G (p.Gln559Arg)
Other names:
NP_078951.2:p.Gln559Arg
HGVS:
  • NC_000016.10:g.23634870T>C
  • NG_007406.1:g.11488A>G
  • NM_024675.4:c.1676A>GMANE SELECT
  • NP_078951.2:p.Gln559Arg
  • NP_078951.2:p.Gln559Arg
  • LRG_308t1:c.1676A>G
  • LRG_308:g.11488A>G
  • LRG_308p1:p.Gln559Arg
  • NC_000016.9:g.23646191T>C
  • NM_024675.3:c.1676A>G
  • Q86YC2:p.Gln559Arg
  • p.Q559R
Protein change:
Q559R
Links:
UniProtKB: Q86YC2#VAR_066369; dbSNP: rs152451
NCBI 1000 Genomes Browser:
rs152451
Molecular consequence:
  • NM_024675.4:c.1676A>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Familial cancer of breast
Synonyms:
Breast cancer, familial; Hereditary breast cancer
Identifiers:
MONDO: MONDO:0016419; MedGen: C0346153; OMIM: 114480

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000268003Cancer Genetics Laboratory, Peter MacCallum Cancer Centre
criteria provided, single submitter

(Thompson et al. (Breast Cancer Res. 2015))
Likely benign
(Jun 1, 2015)
germlinecase-control

PubMed (1)
[See all records that cite this PMID]

SCV001000426Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Benign
(Feb 1, 2024)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV001440258Institute of Human Genetics, University of Leipzig Medical Center
criteria provided, single submitter

(ACMG Guidelines, 2015)
Benign
(Jan 1, 2019)
unknownclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing
not providedgermlineno335not providednot provided1998not providedcase-control
not providedunknownyesnot providednot providednot providednot providednot providedclinical testing
not providedgermlineyes398not providednot provided1996not providedcase-control

Citations

PubMed

Prevalence of PALB2 mutations in Australian familial breast cancer cases and controls.

Thompson ER, Gorringe KL, Rowley SM, Wong-Brown MW, McInerny S, Li N, Trainer AH, Devereux L, Doyle MA, Li J, Lupat R, Delatycki MB; LifePool Investigators., Mitchell G, James PA, Scott RJ, Campbell IG.

Breast Cancer Res. 2015 Aug 19;17:111. doi: 10.1186/s13058-015-0627-7.

PubMed [citation]
PMID:
26283626
PMCID:
PMC4539664

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818
See all PubMed Citations (3)

Details of each submission

From Cancer Genetics Laboratory, Peter MacCallum Cancer Centre, SCV000268003.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided398not providednot providedcase-control PubMed (1)
2not provided335not providednot providedcase-control PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyes1996not providednot provided398not providednot providednot provided
2germlineno1998not providednot provided335not providednot providednot provided

From Labcorp Genetics (formerly Invitae), Labcorp, SCV001000426.6

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Institute of Human Genetics, University of Leipzig Medical Center, SCV001440258.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 10, 2024